Press Releases
Press Releases
Section Title
As India gears up for the Interim Budget 2024-25, the healthcare industry has presented a clear wish list, urging the government to prioritise three key areas: Research and development...
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Gabapentin Tablets (Once-Daily), 300 mg and 600 mg (USRLD: Gralise...
Jan 25 (Reuters) – The U.S. health regulator has approved the use of Regeneron (REGN.O), opens new tab and Sanofi’s (SASY.PA), opens new tab Dupixent to treat an...